Copyright Statement : If you need to reprint, please be sure to contact " Nobel Prize Winners Medical Summit Organizing Committee " Unauthorized reproduction is prohibited
2017·The 4th Nobel Prize Winners Medical Summit Guiyang Conference is about to open grandly! As a high-end service platform linking the Chinese and American medical circles,
is an authoritative conference that has witnessed countless medical changes and technological trends in the four years since its establishment. The 2017 Nobel Laureate Medical Summit once again brings together Nobel laureates, academicians of the Chinese and American Academy of Sciences, well-known medical experts, and global Corporate executives and opinion leaders gathered in Guiyang to discuss the integration and mutual learning of modern medicine and traditional medicine. With the theme of "Science-Fact and Fiction", the
conference will conduct in-depth discussions around four major topics: international precision medicine, traditional Chinese medicine industry innovation, world youth innovation and the international biomedical industry.
htmlSeptember 14th - 16th
Nobel Prize Winner Medical Summit Guiyang Conference
Guiyang City·Guiyang International Ecological Conference Center
1. Nobel Prize winner
Richard • Roberts (Richard J. Roberts)
1993 Nobel Prize in Physiology or Medicine Prize winner
Sir Richard Roberts is the originator of the discovery of break genes and RNA splicing. He pioneered the use of computers for sequence data analysis and published more than 230 academic papers in famous journals such as Science, Nature, and Cell.
Steven Chu
Winner of the 1997 Nobel Prize in Physics
On December 15, 2008, he was nominated by the 56th President-elect Obama of the United States to serve as the 12th Secretary of Energy of the United States. Steven Chu was awarded the King Fessel International Science Prize in 1993; the Arthur Szolow Prize and the William Meggs Prize in 1994; and the Nobel Prize in Physics in 1997.
Barry • Marshall (Barry J. Marshall)
Winner of the 2005 Nobel Prize in Physiology or Medicine
Barry Marshall, Australian scientist, Professor of Clinical Microbiology at the University of Western Australia, Foreign Academician of the Chinese Academy of Engineering. In 2005, Marshall and J. Robin Warren were awarded the 2005 Nobel Prize in Physiology or Medicine for the discovery that Helicobacter pylori (H. pylori) is the main cause of most gastric ulcer diseases.
Robert C. Merton
won the Nobel Prize in Economics in 1997.
Academician of the National Academy of Sciences of the United States. . Robert C. Merton is a professor of finance at Harvard University Business School in the United States. The highest level of "university professor" at Harvard University. Merton, one of the founders of modern finance, received his PhD in economics from MIT in 1970. He studied under Professor Paul Samuelson, a famous economics master and the first American Nobel Prize winner in economics.
Randy • Randy W. Schekman
Winner of the 2013 Nobel Prize in Physiology or Medicine
American cell biologist, professor in the Department of Molecular and Cell Biology at the University of California, Berkeley, and concurrently serving as Howard Hughes Medical Institute Researcher at the Institute. 2013 Award jointly with American scientist James E. Rothman and German scientist Thomas C. Südhof for their discovery of three types of genes that control different aspects of cellular transport systems Nobel Prize in Physiology or Medicine.
2. Chinese and foreign academicians
Steve • Steve A. Kay
Academician of the National Academy of Sciences
Professor Steve Kay is the Dean of the School of Humanities, Arts and Sciences and the Anna H. Bing Emeritus Professor at the University of Southern California . Dr. Kaye is widely known for his research on genes and circadian rhythms. Dr. Kay has published more than 200 scientific research papers and was awarded the ISI "Most Cited Scholar" honor. His research results have become "Scientific Breakthrough of the Year" reported by Science magazine three times.Dr. Kaye was elected to the National Academy of Sciences in 2008 and the American Association for the Advancement of Science in 2009. In 2011, Dr. Kaye received the Martin Gibbs Award from the American Association of Plant Biologists.
Moshe • Moshe Szyf
Fellow of the Royal Canadian Academy of Sciences
Chair of the Pharmacology Funding Committee of the Canadian National Cancer Institute, and also serves on the Canadian Institutes of Health and the US National Institutes of Health Funding Approval Advisory Committee for Novel Anticancer He works in drug and target approval and is the editor-in-chief of the Journal of Contemporary Drug Targets. He is also a member of the Canadian Pharmacological Association, the American Society for Microbiology and the Society for Cell Biology.
Hong Mingqi
Vice President of the University of Texas MD Anderson Cancer Center, Director of the Breast Cancer Basic Research Center, Academician of the American Association for the Advancement of Science (AAAS), and Academician of Taiwan's Academia Sinica.
Zhan Qimin
Academician of the Chinese Academy of Engineering
Director of the Peking University School of Medicine, Director of the State Key Laboratory of Molecular Oncology, Leader of the National 863 High-Tech Program "Eleventh Five-Year Plan" Expert Group in the Biological and Medical Fields, National 973 Major Basic Research Project (Tumor Metastasis) ) Chief Scientist, Chairman of the Chinese Microcirculation Society, Vice Chairman of the Chinese Anti-Cancer Society.
Chen Kaixian
Academician of the Chinese Academy of Sciences, medicinal chemist
Chairman of the Shanghai Science and Technology Association, deputy chief technical engineer of the national major science and technology project "Major New Drug Creation", leader of the Chemical Drug Responsibility Expert Group, vice chairman of the Chinese Pharmaceutical Association, and member of the Central Committee of the Communist Party of China Vice President of the Medical Association.
Fan Daiming
Academician of the Chinese Academy of Engineering, former president of the Fourth Military Medical University
Director of the State Key Laboratory of Tumor Biology, Distinguished Professor of the National Education Yangtze River Scholars Award Program, Chief Scientist of the National 973 Project, Representative of the 14th National Congress of the Communist Party of China, Eleventh National Representatives of the National People's Congress. The first batch of recipients of the National Special Fund for Outstanding Young and Middle-aged Talents and the National Fund for Outstanding Youth, and the first batch of academic leaders of innovative research groups.
Wang Cunyu
Academician of the National Academy of Medicine of the United States, and Foreign Academician of the Chinese Academy of Engineering.
His main research areas include the regulation and metastasis of tumor cell apoptosis, the pathogenesis of oral inflammation, metabolic bone loss, and the molecular regulation of differentiation of oral stem cells. He is currently the chairman and professor of the Department of Oral Biology and Medicine at the University of California, Los Angeles. He has conducted a series of international cutting-edge research in the fields of the relationship between Wnt signaling and apoptosis, tumor development and immortalization of adult stem cells, and has achieved innovative research achievements recognized by international peers. He won the IADR's "Young Investigator" Award and the "Gie Award" (JDR Best Paper Award). The laboratory he leads has received funding from the National Institutes of Health for many times in the fields of stem cells, tumors, and inflammation.
Wu Yiling
Academician of the Chinese Academy of Engineering, famous TCM cardiovascular disease expert
Founder and academic leader of the discipline of collateral diseases of traditional Chinese medicine, President of the Hebei Institute of Integrated Traditional Chinese and Western Medicine, National 973 Chief Scientist, Mentor of the Postdoctoral Research Station of the Ministry of Personnel, Member of the National Committee of the Chinese People's Political Consultative Conference, executive director of the China Society of Integrated Traditional Chinese and Western Medicine, chairman of the Collateral Disease Branch of the Chinese Society of Traditional Chinese Medicine, deputy chairman of the Expert Committee of the National Center for Cardiovascular Diseases, director of the Collateral Disease Key Research Office of the State Administration of Traditional Chinese Medicine, and director of the Chinese Medicine Association of China Vice president of the society.
Zhang Xuemin
Academician of the Chinese Academy of Sciences
Doctoral supervisor at the Institute of Toxicology and Drugs, Academy of Military Medical Sciences, currently engaged in subject expertise: tumor biology research, scientific research direction: tumor occurrence and intervention. Served as the chief scientist of the "National Major Scientific Research Plan" project and the "National 863 Plan" major project in the field of biomedicine.
Zhang Boli
Academician of the Chinese Academy of Engineering, President of the China Academy of Chinese Medical Sciences, Tianjin University of Traditional Chinese Medicine President
National key discipline leader of Traditional Chinese Medicine Internal Medicine, Deputy Chief Technical Engineer of the National Major New Drug Creation Science and Technology Project, Educational Director of the World Federation of Chinese Medicine Societies Chairman of the committee, vice president of the Chinese Society of Integrated Traditional Chinese and Western Medicine, vice chairman of the Internal Medicine Branch of the Chinese Society of Traditional Chinese Medicine, and chairman of the Education Steering Committee of the World Federation of Chinese Medicine Societies.
Zhang Daning
The second batch of " Masters of Chinese Medicine" in the country, a librarian of the Central Museum of Culture and History, and an academician of the International Eurasian Academy of Sciences
Since the 1990s, he has been awarded the title of Outstanding Central Health Doctor by the central government. Chairman of the National Society of Traditional Chinese Medicine and Nephrology, President of the China Association for the Promotion of Traditional Chinese Medicine Research, Honorary President of the Tianjin Institute of Traditional Chinese Medicine, Director of the Tianjin Institute of Traditional Chinese Medicine and Nephrology, and the founder of Traditional Chinese Medicine Nephrology. In 1998, the International Astronomical Union named China The newly discovered asteroid No. 8311 by the Academy of Sciences was named "Zhang Daning Star".
Chen Shilin
Academician of the International Eurasian Academy of Sciences, Director of the Institute of Pharmacy, Chinese Academy of Chinese Medical Sciences
Director of the World Health Organization Traditional Medicine Joint Center; Vice Chairman of CGCM (Consortium for the Globalization of Traditional Chinese Medicine), Head of the Yangtze River Scholars Innovation Team of the Ministry of Education. He concurrently serves as the director of the "National Engineering Laboratory for the Breeding of Endangered Medicinal Materials", the chairman of the Traditional Chinese Medicine and Natural Medicine Professional Committee of the Chinese Pharmaceutical Association, and the consultant of the Traditional Chinese Medicine Advisory Group of the United States Pharmacopoeia.
3. Well-known experts
Huang Xiaojun
Director of the Institute of Hematology at Peking University
He has been engaged in clinical and experimental research on blood diseases since 1989 and has rich experience in the diagnosis and treatment of common blood diseases, especially in hematopoietic stem cell transplantation (HSCT). ), we have accumulated rich clinical diagnosis and treatment experience in the diagnosis and treatment of various transplant complications such as graft-versus-host disease (GVHD), infection and recurrence, and have solved many difficult and complicated diseases. He has profound knowledge in the fields of fungal infection and transplantation immunity.
Han Weidong
Molecular immunology expert
Director of the Molecular Immunology Research Office of the People's Liberation Army General Hospital. He is mainly engaged in tumor treatment resistance mechanism and clinical research, and basic and clinical research on stem cells and tissue regeneration. It established the first biotherapy translational medicine ward of the People's Liberation Army General Hospital and took the lead in establishing a "front shop and back factory" translational medicine model in China. Established a number of tumor-targeted immune cell therapy systems, took the lead in registering with international clinical trial institutions and conducted multiple clinical trials of CART therapy, and obtained corporate transformation.
Liu Shangyi
Master of traditional Chinese medicine, chief physician, professor and doctoral supervisor of Guizhou Provincial Hospital of Traditional Chinese Medicine
Instructor of the third, fourth and fifth batch of national famous traditional Chinese medicine practitioners, and the first batch of famous traditional Chinese medicine doctors in Guizhou Province. Former President and Party Secretary of the First Affiliated Hospital of Guiyang College of Traditional Chinese Medicine. In the diagnosis and treatment of traditional Chinese medicine miscellaneous diseases such as kidney disease, spleen and stomach disease, and external ulcer diseases, significant curative effects have been achieved and academic achievements have attracted attention. He has published more than 20 papers and edited or co-edited 11 national-level published books.
Mou Juwei
Deputy Director of the Thoracic Surgery Department of the National Cancer Center, Chinese Academy of Medical Sciences Cancer Hospital
Chief physician, professor, and doctoral supervisor. Member of the Expert Committee for Standardized Diagnosis and Treatment of Lung Cancer of the National Health and Family Planning Commission, deputy chairman of the Thoracic Oncology Branch of the Chinese Association for Medical Promotion, deputy secretary-general of the Standing Committee of the Thoracic Surgery Branch, member of the Esophageal Cancer Group of the Thoracoscopy Group of the Thoracic and Cardio Surgery Branch of the Chinese Medical Association, and Thoracic Cancer Group of the Chinese Medical Doctor Association. Member of the Rapid Recovery Group of the Surgery Branch, standing committee member of the Guangdong Branch, vice chairman of the World Association of Chinese Oncologists, the first chairman of the Thoracic Oncology Committee, and the first vice president of the Thoracic Surgeons Branch of the Shenzhen Medical Doctors Association. He is a member of the Expert Committee of Beijing Cancer Standardized Diagnosis and Treatment Quality Control Center and a member of the Medical Accident Appraisal Expert Committee of Beijing Medical Association.Deputy editor-in-chief of the editorial board of World Journal of Gastroenterology, JTD and other magazines, co-edited 5 monographs, and presided over more than 10 projects including National Nature, Northern Nature Key, Beijing Science and Technology Commission, Collaborative Innovation in Oncology and National Major Special Projects.
Qin Jun
Director of the Beijing Proteome Research Center
Professor at Baylor College of Medicine in the United States, Director of the Center for Molecular Research and Pathway Discovery, a well-known biological mass spectrometer and biochemist, with expertise in mass spectrometry instrument design, proteome research method advances and biological research. He has certain attainments in the field, especially in DNA damage response, discovery of nuclear hormones through isolation and identification of endogenous protein complexes, identification of post-translational modifications in vivo and interpretation of functional properties. He has published more than 100 research papers, including many papers published as the responsible author in Cell, MolCell, Genes Developments and P Natl Acad Sci USA.
Xiong Jibai
Master of Traditional Chinese Medicine, Hunan University of Chinese MedicineProfessor
Graduate Tutor, Guangzhou University of Chinese MedicineDoctoral Tutor, Honorary Professor of Hong Kong Baptist University. He has successively served as the director of the Teaching and Research Office of Traditional Chinese Medicine Classics and Ancient Books, a member of the Academic Committee, and a member of the Internal Economics Professional Committee of the Chinese Association of Traditional Chinese Medicine. He is good at syndrome differentiation and treatment, selecting prescriptions according to the syndrome, and using medicine according to the prescription. He is a well-known expert of traditional Chinese medicine at home and abroad.
Xing Ligang
Director of the 10th Radiotherapy Ward and Chief of the Scientific Research Department of Shandong Provincial Cancer Hospital, member of the Radiation Oncology Branch of the Chinese Medical Association, member of the Radiation Biology Group, member of the Stereotactic Radiotherapy Group, majoring in tumor radiotherapy of the Chinese Anti-Cancer Association Committee member, member of the Cancer Rehabilitation and Palliative Care Branch of the Chinese Anti-Cancer Association, and leader of the radiotherapy group.
Xu Binghe
Deputy director of the Department of Internal Medicine and the Breast Disease Diagnosis and Treatment Center of the Cancer Hospital of the Chinese Academy of Medical Sciences and China Union Medical University, and the head of the Clinical Pharmacology Office of the National New Drug Clinical Research Base. Professor, doctoral supervisor; part-time new drug review expert of the State Food and Drug Administration, member of the Standing Committee of the Clinical Oncology Collaboration Professional Committee and Breast Cancer Professional Committee of the Chinese Anti-Cancer Association, deputy director of the Oncology Professional Committee of the Beijing Society of Integrated Traditional Chinese and Western Medicine, He is a member of the Academic Committee of the Chinese Academy of Medical Sciences and a review member of the National Science and Technology Progress Award and Technology Invention Award.
Yang Zhu
Dean of Guiyang College of Traditional Chinese Medicine Professor, doctoral supervisor, and former deputy secretary of the party committee and president of Qiannan Normal University for Nationalities. His research directions are higher education and the etiology and pathogenesis of basic theories of traditional Chinese medicine. He is the president of the Guizhou Provincial Traditional Chinese Medicine Multidisciplinary Research Association and the vice president of the Guizhou Provincial Confucian Research Association.
Zhou Caicun
Director of the Institute of Oncology, Tongji University School of Medicine, Director of the Department of Oncology, Director of the Oncology Department of Shanghai Pulmonary Hospital
Mainly engaged in early diagnosis, comprehensive treatment, targeted therapy and individualized treatment of lung cancer, molecular manifestation of tumors Like, phage vaccines. In 2007, he was selected into the second batch of outstanding subject leaders by the Shanghai Municipal Science and Technology Commission. Currently, it is undertaking 1 national project, 1 National Natural Science Foundation project, 2 major research projects of the Shanghai Anti-Resistance Science and Technology Commission, and participating in 2 national 11th Five-Year Plan projects. Member of the Lung Cancer Professional Committee of the Chinese Anti-Cancer Association, member of CSCO, and member of ASCO.
Zaipal Abriz
Expert in the fields of analytical chemistry, drug analysis and metabolomics
Vice president and professor of Minzu University of China; Researcher and doctoral supervisor of the Institute of Materia Medica, Chinese Academy of Medical Sciences and Peking Union Medical College; Associate Dean of the Institute of Materia Medica Chang, deputy director of the State Key Laboratory of Active Substances and Functions of Natural Medicines. Chief expert of the national “863” program, member of the 7th Pharmacy Discipline Evaluation Group of the Academic Degrees Committee of the State Council, and member of the 7th Science and Technology Committee of the Ministry of Education.
Zhang Ting
Researcher at the Capital Institute of Pediatrics, doctoral tutor, director of the Beijing Key Laboratory of Child Development Nutritionomics
Currently, he is the deputy director of the Child Health Professional Committee of the Chinese Society of Preventive Medicine, and the early childhood development of the National Maternal and Child Health Research Association Deputy chairman of the professional committee, deputy editor-in-chief of the pediatric volume of the Chinese Medical Encyclopedia, and executive director of the Chinese Society of Microbiology. Since the 11th Five-Year Plan period, he has successively undertaken many national “973 Program” projects and National Natural Science Foundation projects in the field of birth defects research, and is the chief scientist of the National Science and Technology Support Plan project “Research on Key Technologies and Applications of Primary Prevention and Early Warning of Pregnancy Birth Defects” .
Zhang Luxia
Deputy Chief Physician of Peking University Hospital, Doctor of Medicine. She received her Doctor of Medicine from Peking University School of Medicine in 2004 and was promoted to Deputy Chief Physician in 2008. In 2008, he studied for a master's degree in public health at Harvard School of Public Health, funded by the International Society of Nephrology (ISN).
Copyright Statement : If you need to reprint, please be sure to contact " Nobel Prize Winners Medical Summit Organizing Committee " Unauthorized reproduction is prohibited
2017·The 4th Nobel Prize Winners Medical Summit Guiyang Conference is about to open grandly! As a high-end service platform linking the Chinese and American medical circles,
is an authoritative conference that has witnessed countless medical changes and technological trends in the four years since its establishment. The 2017 Nobel Laureate Medical Summit once again brings together Nobel laureates, academicians of the Chinese and American Academy of Sciences, well-known medical experts, and global Corporate executives and opinion leaders gathered in Guiyang to discuss the integration and mutual learning of modern medicine and traditional medicine. With the theme of "Science-Fact and Fiction", the
conference will conduct in-depth discussions around four major topics: international precision medicine, traditional Chinese medicine industry innovation, world youth innovation and the international biomedical industry.
htmlSeptember 14th - 16th
Nobel Prize Winner Medical Summit Guiyang Conference
Guiyang City·Guiyang International Ecological Conference Center
1. Nobel Prize winner
Richard • Roberts (Richard J. Roberts)
1993 Nobel Prize in Physiology or Medicine Prize winner
Sir Richard Roberts is the originator of the discovery of break genes and RNA splicing. He pioneered the use of computers for sequence data analysis and published more than 230 academic papers in famous journals such as Science, Nature, and Cell.
Steven Chu
Winner of the 1997 Nobel Prize in Physics
On December 15, 2008, he was nominated by the 56th President-elect Obama of the United States to serve as the 12th Secretary of Energy of the United States. Steven Chu was awarded the King Fessel International Science Prize in 1993; the Arthur Szolow Prize and the William Meggs Prize in 1994; and the Nobel Prize in Physics in 1997.
Barry • Marshall (Barry J. Marshall)
Winner of the 2005 Nobel Prize in Physiology or Medicine
Barry Marshall, Australian scientist, Professor of Clinical Microbiology at the University of Western Australia, Foreign Academician of the Chinese Academy of Engineering. In 2005, Marshall and J. Robin Warren were awarded the 2005 Nobel Prize in Physiology or Medicine for the discovery that Helicobacter pylori (H. pylori) is the main cause of most gastric ulcer diseases.
Robert C. Merton
won the Nobel Prize in Economics in 1997.
Academician of the National Academy of Sciences of the United States. . Robert C. Merton is a professor of finance at Harvard University Business School in the United States. The highest level of "university professor" at Harvard University. Merton, one of the founders of modern finance, received his PhD in economics from MIT in 1970. He studied under Professor Paul Samuelson, a famous economics master and the first American Nobel Prize winner in economics.
Randy • Randy W. Schekman
Winner of the 2013 Nobel Prize in Physiology or Medicine
American cell biologist, professor in the Department of Molecular and Cell Biology at the University of California, Berkeley, and concurrently serving as Howard Hughes Medical Institute Researcher at the Institute. 2013 Award jointly with American scientist James E. Rothman and German scientist Thomas C. Südhof for their discovery of three types of genes that control different aspects of cellular transport systems Nobel Prize in Physiology or Medicine.
2. Chinese and foreign academicians
Steve • Steve A. Kay
Academician of the National Academy of Sciences
Professor Steve Kay is the Dean of the School of Humanities, Arts and Sciences and the Anna H. Bing Emeritus Professor at the University of Southern California . Dr. Kaye is widely known for his research on genes and circadian rhythms. Dr. Kay has published more than 200 scientific research papers and was awarded the ISI "Most Cited Scholar" honor. His research results have become "Scientific Breakthrough of the Year" reported by Science magazine three times.Dr. Kaye was elected to the National Academy of Sciences in 2008 and the American Association for the Advancement of Science in 2009. In 2011, Dr. Kaye received the Martin Gibbs Award from the American Association of Plant Biologists.
Moshe • Moshe Szyf
Fellow of the Royal Canadian Academy of Sciences
Chair of the Pharmacology Funding Committee of the Canadian National Cancer Institute, and also serves on the Canadian Institutes of Health and the US National Institutes of Health Funding Approval Advisory Committee for Novel Anticancer He works in drug and target approval and is the editor-in-chief of the Journal of Contemporary Drug Targets. He is also a member of the Canadian Pharmacological Association, the American Society for Microbiology and the Society for Cell Biology.
Hong Mingqi
Vice President of the University of Texas MD Anderson Cancer Center, Director of the Breast Cancer Basic Research Center, Academician of the American Association for the Advancement of Science (AAAS), and Academician of Taiwan's Academia Sinica.
Zhan Qimin
Academician of the Chinese Academy of Engineering
Director of the Peking University School of Medicine, Director of the State Key Laboratory of Molecular Oncology, Leader of the National 863 High-Tech Program "Eleventh Five-Year Plan" Expert Group in the Biological and Medical Fields, National 973 Major Basic Research Project (Tumor Metastasis) ) Chief Scientist, Chairman of the Chinese Microcirculation Society, Vice Chairman of the Chinese Anti-Cancer Society.
Chen Kaixian
Academician of the Chinese Academy of Sciences, medicinal chemist
Chairman of the Shanghai Science and Technology Association, deputy chief technical engineer of the national major science and technology project "Major New Drug Creation", leader of the Chemical Drug Responsibility Expert Group, vice chairman of the Chinese Pharmaceutical Association, and member of the Central Committee of the Communist Party of China Vice President of the Medical Association.
Fan Daiming
Academician of the Chinese Academy of Engineering, former president of the Fourth Military Medical University
Director of the State Key Laboratory of Tumor Biology, Distinguished Professor of the National Education Yangtze River Scholars Award Program, Chief Scientist of the National 973 Project, Representative of the 14th National Congress of the Communist Party of China, Eleventh National Representatives of the National People's Congress. The first batch of recipients of the National Special Fund for Outstanding Young and Middle-aged Talents and the National Fund for Outstanding Youth, and the first batch of academic leaders of innovative research groups.
Wang Cunyu
Academician of the National Academy of Medicine of the United States, and Foreign Academician of the Chinese Academy of Engineering.
His main research areas include the regulation and metastasis of tumor cell apoptosis, the pathogenesis of oral inflammation, metabolic bone loss, and the molecular regulation of differentiation of oral stem cells. He is currently the chairman and professor of the Department of Oral Biology and Medicine at the University of California, Los Angeles. He has conducted a series of international cutting-edge research in the fields of the relationship between Wnt signaling and apoptosis, tumor development and immortalization of adult stem cells, and has achieved innovative research achievements recognized by international peers. He won the IADR's "Young Investigator" Award and the "Gie Award" (JDR Best Paper Award). The laboratory he leads has received funding from the National Institutes of Health for many times in the fields of stem cells, tumors, and inflammation.
Wu Yiling
Academician of the Chinese Academy of Engineering, famous TCM cardiovascular disease expert
Founder and academic leader of the discipline of collateral diseases of traditional Chinese medicine, President of the Hebei Institute of Integrated Traditional Chinese and Western Medicine, National 973 Chief Scientist, Mentor of the Postdoctoral Research Station of the Ministry of Personnel, Member of the National Committee of the Chinese People's Political Consultative Conference, executive director of the China Society of Integrated Traditional Chinese and Western Medicine, chairman of the Collateral Disease Branch of the Chinese Society of Traditional Chinese Medicine, deputy chairman of the Expert Committee of the National Center for Cardiovascular Diseases, director of the Collateral Disease Key Research Office of the State Administration of Traditional Chinese Medicine, and director of the Chinese Medicine Association of China Vice president of the society.
Zhang Xuemin
Academician of the Chinese Academy of Sciences
Doctoral supervisor at the Institute of Toxicology and Drugs, Academy of Military Medical Sciences, currently engaged in subject expertise: tumor biology research, scientific research direction: tumor occurrence and intervention. Served as the chief scientist of the "National Major Scientific Research Plan" project and the "National 863 Plan" major project in the field of biomedicine.
Zhang Boli
Academician of the Chinese Academy of Engineering, President of the China Academy of Chinese Medical Sciences, Tianjin University of Traditional Chinese Medicine President
National key discipline leader of Traditional Chinese Medicine Internal Medicine, Deputy Chief Technical Engineer of the National Major New Drug Creation Science and Technology Project, Educational Director of the World Federation of Chinese Medicine Societies Chairman of the committee, vice president of the Chinese Society of Integrated Traditional Chinese and Western Medicine, vice chairman of the Internal Medicine Branch of the Chinese Society of Traditional Chinese Medicine, and chairman of the Education Steering Committee of the World Federation of Chinese Medicine Societies.
Zhang Daning
The second batch of " Masters of Chinese Medicine" in the country, a librarian of the Central Museum of Culture and History, and an academician of the International Eurasian Academy of Sciences
Since the 1990s, he has been awarded the title of Outstanding Central Health Doctor by the central government. Chairman of the National Society of Traditional Chinese Medicine and Nephrology, President of the China Association for the Promotion of Traditional Chinese Medicine Research, Honorary President of the Tianjin Institute of Traditional Chinese Medicine, Director of the Tianjin Institute of Traditional Chinese Medicine and Nephrology, and the founder of Traditional Chinese Medicine Nephrology. In 1998, the International Astronomical Union named China The newly discovered asteroid No. 8311 by the Academy of Sciences was named "Zhang Daning Star".
Chen Shilin
Academician of the International Eurasian Academy of Sciences, Director of the Institute of Pharmacy, Chinese Academy of Chinese Medical Sciences
Director of the World Health Organization Traditional Medicine Joint Center; Vice Chairman of CGCM (Consortium for the Globalization of Traditional Chinese Medicine), Head of the Yangtze River Scholars Innovation Team of the Ministry of Education. He concurrently serves as the director of the "National Engineering Laboratory for the Breeding of Endangered Medicinal Materials", the chairman of the Traditional Chinese Medicine and Natural Medicine Professional Committee of the Chinese Pharmaceutical Association, and the consultant of the Traditional Chinese Medicine Advisory Group of the United States Pharmacopoeia.
3. Well-known experts
Huang Xiaojun
Director of the Institute of Hematology at Peking University
He has been engaged in clinical and experimental research on blood diseases since 1989 and has rich experience in the diagnosis and treatment of common blood diseases, especially in hematopoietic stem cell transplantation (HSCT). ), we have accumulated rich clinical diagnosis and treatment experience in the diagnosis and treatment of various transplant complications such as graft-versus-host disease (GVHD), infection and recurrence, and have solved many difficult and complicated diseases. He has profound knowledge in the fields of fungal infection and transplantation immunity.
Han Weidong
Molecular immunology expert
Director of the Molecular Immunology Research Office of the People's Liberation Army General Hospital. He is mainly engaged in tumor treatment resistance mechanism and clinical research, and basic and clinical research on stem cells and tissue regeneration. It established the first biotherapy translational medicine ward of the People's Liberation Army General Hospital and took the lead in establishing a "front shop and back factory" translational medicine model in China. Established a number of tumor-targeted immune cell therapy systems, took the lead in registering with international clinical trial institutions and conducted multiple clinical trials of CART therapy, and obtained corporate transformation.
Liu Shangyi
Master of traditional Chinese medicine, chief physician, professor and doctoral supervisor of Guizhou Provincial Hospital of Traditional Chinese Medicine
Instructor of the third, fourth and fifth batch of national famous traditional Chinese medicine practitioners, and the first batch of famous traditional Chinese medicine doctors in Guizhou Province. Former President and Party Secretary of the First Affiliated Hospital of Guiyang College of Traditional Chinese Medicine. In the diagnosis and treatment of traditional Chinese medicine miscellaneous diseases such as kidney disease, spleen and stomach disease, and external ulcer diseases, significant curative effects have been achieved and academic achievements have attracted attention. He has published more than 20 papers and edited or co-edited 11 national-level published books.
Mou Juwei
Deputy Director of the Thoracic Surgery Department of the National Cancer Center, Chinese Academy of Medical Sciences Cancer Hospital
Chief physician, professor, and doctoral supervisor. Member of the Expert Committee for Standardized Diagnosis and Treatment of Lung Cancer of the National Health and Family Planning Commission, deputy chairman of the Thoracic Oncology Branch of the Chinese Association for Medical Promotion, deputy secretary-general of the Standing Committee of the Thoracic Surgery Branch, member of the Esophageal Cancer Group of the Thoracoscopy Group of the Thoracic and Cardio Surgery Branch of the Chinese Medical Association, and Thoracic Cancer Group of the Chinese Medical Doctor Association. Member of the Rapid Recovery Group of the Surgery Branch, standing committee member of the Guangdong Branch, vice chairman of the World Association of Chinese Oncologists, the first chairman of the Thoracic Oncology Committee, and the first vice president of the Thoracic Surgeons Branch of the Shenzhen Medical Doctors Association. He is a member of the Expert Committee of Beijing Cancer Standardized Diagnosis and Treatment Quality Control Center and a member of the Medical Accident Appraisal Expert Committee of Beijing Medical Association.Deputy editor-in-chief of the editorial board of World Journal of Gastroenterology, JTD and other magazines, co-edited 5 monographs, and presided over more than 10 projects including National Nature, Northern Nature Key, Beijing Science and Technology Commission, Collaborative Innovation in Oncology and National Major Special Projects.
Qin Jun
Director of the Beijing Proteome Research Center
Professor at Baylor College of Medicine in the United States, Director of the Center for Molecular Research and Pathway Discovery, a well-known biological mass spectrometer and biochemist, with expertise in mass spectrometry instrument design, proteome research method advances and biological research. He has certain attainments in the field, especially in DNA damage response, discovery of nuclear hormones through isolation and identification of endogenous protein complexes, identification of post-translational modifications in vivo and interpretation of functional properties. He has published more than 100 research papers, including many papers published as the responsible author in Cell, MolCell, Genes Developments and P Natl Acad Sci USA.
Xiong Jibai
Master of Traditional Chinese Medicine, Hunan University of Chinese MedicineProfessor
Graduate Tutor, Guangzhou University of Chinese MedicineDoctoral Tutor, Honorary Professor of Hong Kong Baptist University. He has successively served as the director of the Teaching and Research Office of Traditional Chinese Medicine Classics and Ancient Books, a member of the Academic Committee, and a member of the Internal Economics Professional Committee of the Chinese Association of Traditional Chinese Medicine. He is good at syndrome differentiation and treatment, selecting prescriptions according to the syndrome, and using medicine according to the prescription. He is a well-known expert of traditional Chinese medicine at home and abroad.
Xing Ligang
Director of the 10th Radiotherapy Ward and Chief of the Scientific Research Department of Shandong Provincial Cancer Hospital, member of the Radiation Oncology Branch of the Chinese Medical Association, member of the Radiation Biology Group, member of the Stereotactic Radiotherapy Group, majoring in tumor radiotherapy of the Chinese Anti-Cancer Association Committee member, member of the Cancer Rehabilitation and Palliative Care Branch of the Chinese Anti-Cancer Association, and leader of the radiotherapy group.
Xu Binghe
Deputy director of the Department of Internal Medicine and the Breast Disease Diagnosis and Treatment Center of the Cancer Hospital of the Chinese Academy of Medical Sciences and China Union Medical University, and the head of the Clinical Pharmacology Office of the National New Drug Clinical Research Base. Professor, doctoral supervisor; part-time new drug review expert of the State Food and Drug Administration, member of the Standing Committee of the Clinical Oncology Collaboration Professional Committee and Breast Cancer Professional Committee of the Chinese Anti-Cancer Association, deputy director of the Oncology Professional Committee of the Beijing Society of Integrated Traditional Chinese and Western Medicine, He is a member of the Academic Committee of the Chinese Academy of Medical Sciences and a review member of the National Science and Technology Progress Award and Technology Invention Award.
Yang Zhu
Dean of Guiyang College of Traditional Chinese Medicine Professor, doctoral supervisor, and former deputy secretary of the party committee and president of Qiannan Normal University for Nationalities. His research directions are higher education and the etiology and pathogenesis of basic theories of traditional Chinese medicine. He is the president of the Guizhou Provincial Traditional Chinese Medicine Multidisciplinary Research Association and the vice president of the Guizhou Provincial Confucian Research Association.
Zhou Caicun
Director of the Institute of Oncology, Tongji University School of Medicine, Director of the Department of Oncology, Director of the Oncology Department of Shanghai Pulmonary Hospital
Mainly engaged in early diagnosis, comprehensive treatment, targeted therapy and individualized treatment of lung cancer, molecular manifestation of tumors Like, phage vaccines. In 2007, he was selected into the second batch of outstanding subject leaders by the Shanghai Municipal Science and Technology Commission. Currently, it is undertaking 1 national project, 1 National Natural Science Foundation project, 2 major research projects of the Shanghai Anti-Resistance Science and Technology Commission, and participating in 2 national 11th Five-Year Plan projects. Member of the Lung Cancer Professional Committee of the Chinese Anti-Cancer Association, member of CSCO, and member of ASCO.
Zaipal Abriz
Expert in the fields of analytical chemistry, drug analysis and metabolomics
Vice president and professor of Minzu University of China; Researcher and doctoral supervisor of the Institute of Materia Medica, Chinese Academy of Medical Sciences and Peking Union Medical College; Associate Dean of the Institute of Materia Medica Chang, deputy director of the State Key Laboratory of Active Substances and Functions of Natural Medicines. Chief expert of the national “863” program, member of the 7th Pharmacy Discipline Evaluation Group of the Academic Degrees Committee of the State Council, and member of the 7th Science and Technology Committee of the Ministry of Education.
Zhang Ting
Researcher at the Capital Institute of Pediatrics, doctoral tutor, director of the Beijing Key Laboratory of Child Development Nutritionomics
Currently, he is the deputy director of the Child Health Professional Committee of the Chinese Society of Preventive Medicine, and the early childhood development of the National Maternal and Child Health Research Association Deputy chairman of the professional committee, deputy editor-in-chief of the pediatric volume of the Chinese Medical Encyclopedia, and executive director of the Chinese Society of Microbiology. Since the 11th Five-Year Plan period, he has successively undertaken many national “973 Program” projects and National Natural Science Foundation projects in the field of birth defects research, and is the chief scientist of the National Science and Technology Support Plan project “Research on Key Technologies and Applications of Primary Prevention and Early Warning of Pregnancy Birth Defects” .
Zhang Luxia
Deputy Chief Physician of Peking University Hospital, Doctor of Medicine. She received her Doctor of Medicine from Peking University School of Medicine in 2004 and was promoted to Deputy Chief Physician in 2008. In 2008, he studied for a master's degree in public health at Harvard School of Public Health, funded by the International Society of Nephrology (ISN).
4. Guests from domestic and foreign investors
| John Mackenzie | CEO of Roslin Biotechnology Center in the UK |
| Tom Ichim | President of Bata Company in the United States |
| Michael Melnick | Vice President of Bioatla Company in the United States |
| Jay Rhee | President of Precision-Bio Company in South Korea |
| John Wu (Wu Lijun) | President of Promab Biotechnology Company in the United States |
| Maynard Howe | United States Chairman of Stemedica Company |
| Harvey Eisenberg | President of HyperScan Company of the United States |
| Gary Li | President of Alstem Company of the United States |
| Dan Alminara | Chief Scientist of Elysium Company of the United States |
| Michael Gresser | Imm of the United States Chief Scientist of uneGene Company |
| Johanna Holldack | President of Trethera Company in the United States |
| Michael Newman | Chairman of Decoy Biosystems Company in the United States |
| Ziyong Wang | ADS Biosystems Company in the United States President |
| Radu Pislariuhm41 | President of Laurent Pharmaceutical Company of Canada |
| Pierre Sevigny | President of IDGel Company of Canada |
| Don Wang | President of Gentury Company of the United States |
| Pan Guangcheng | Executive President of China Chemical and Pharmaceutical Industry Association 1 |
| He Ruyi | Chief Scientist of National Center for Drug Evaluation |
| Zhao Gang | Director of Global Innovation Center, Researcher of the Strategic Research Institute of the Ministry of Science and Technology |
| Wu Haidong | Deputy Director of the Consumer Products Department of the Ministry of Industry and Information Technology |
| Sun Piaoyang | Chairman of Jiangsu Hengrui Pharmaceutical Co., Ltd. |
| Li Xiaoqiang | Lianchuang Investment Partner |
| Wu Xiaobin | Pfizer Investment Co., Ltd. China President |
| Chen Qiyu | President of Shanghai Fosun Pharmaceutical (Group) |
| Bai Hua | Chairman of Zhejiang Hisheng Pharmaceutical Co., Ltd. |
| Ke Zunhong | Chairman of Chengdu Kanghong Pharmaceutical Group |
| Wang Hui | Founding Partner of Honghui Capital |
| Yang Sheng | Drug and Cosmetic Registration Deputy Director of the Department |
| Yang Suming | Chairman of Sino-American Shanghai Bristol-Myers Squibb Pharmaceutical Co., Ltd. |
| Yu Rong | Chairman of Meinian Health Group |
| Zuo Min | President of Shanghai Pharmaceutical Group Co., Ltd. |
| Zhang Dan | Chairman of Fountain Pharmaceutical Co., Ltd. |
| Hu Jiangbin | Deputy General Manager of Huahai Pharmaceutical Co., Ltd. and Senior Vice President of Huahai America |
| Jiang Hua | Vice President of Luye Pharmaceutical Group |
| Hong Zhi | Senior Vice President of Global R&D in the Anti-Infectious Diseases Area of GlaxoSmithKline (USA) |
| Guo Tongjun | Lepu Vice President of Medical |
| Lu Yun | Dean of Hengrui Research Institute |
| Zhang Ziran | Executive Director of China Investment and Finance Fund |
| Bao Zhihua | Deputy Director of Beijing Changping District Investment Promotion Bureau |
| Zhang Yue | Partner of Baiao Wealth Fund |
| Yang Yunxia | Sequoia Managing Director of Capital China Fund |
| Guo Ying | Deputy General Manager of the Investment Banking Division of Ping An Securities |
| Jiang Weina | Chief Analyst of the Pharmaceutical Industry of Guosen Securities |
| Zhang Yizhuo | General Manager of Investment of Huabang Life Health Co., Ltd. |
| Gong Zhaolong | CEO of Silidi |
| Lu Lirong | Zhongguancun Vice President of Development Group Leading Financial Capital |
| Kang Wei | Deputy General Manager of Beijing Fresenius Kabi Pharmaceuticals |
| Feng Hao | Deputy General Manager and Secretary of the Board of Directors of Sichuan Kelun Pharmaceutical Co., Ltd. |
